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Altered glomerular permeability in the early phase of immune complex
nephritis. We investigated the pathogenesis of increased glomerular
permeability in Balb/c mice after 5 weeks of administration of a
polyclonal B cell activator (bacterial lipopolysaccharide). The glomeru-
lar transfer of anionic ferritin across the capillary walls and the urinary
excretion of serum albumin served as probes of glomerular permeabili-
ty; anionic groups of the glomerular basement membrane were assessed
by the binding of cationized ferritin, and glomeruli were studied by
light, immunofluorescence, and electron microscopy. The mice devel-
oped circulating immune complexes, proteinuria, and a proliferative
glomerulonephritis, with mesangial and capillary ioop deposits of
immunoreactants. Increased transfer of anionic ferritin molecules oc-
curred across capillary walls with and without demonstrable electron-
dense deposits; detachments of visceral epithelium were not seen, and
epithelial transport of anionic ferritin was negligible. Loss of anionic
groups was extensive in glomerular capillary loops with and without
associated electron-dense deposits. The findings indicate that an in-
crease in glomerular permeability may precede the deposition of
immunoreactants in the capillary wall; that filtration of macromolecules
can occur across capillary walls with or without demonstrable immune
deposits; and that loss of anionic groups of the glomerular basement
membrane and enhanced filtration of macromolecules can occur in the
absence of focal detachments of the visceral epithelium.
Alteration de Ia permeabilité glomerulaire a Ia phase précoce d'une
nephrite a complexes immuns. Nous avons étudié Ia pathogenie de
I'augmentation de Ia perméabilité glomérulaire chez des souris Balb/c
aprCs 5 semaines d'administration d'un activateur polyclonal des cel-
lules B (lipopolysaccharide bactérien). Le transfert glomérulaire de
ferritine anionique a travers les parois capillaires et l'excrétion urinaire
de serum albumine ont été utilisés comme marqueur de Ia perméabilité
glomérulaire; les groupes anioniques de Ia membrane basale gloméru-
laire étaient mesurés par Ia liaison de Ia ferritine cationisée, et les
glomCrules étaient étudiés par microscopic optique, en immunofluores-
cence et Clectronique. Les souris ont développé des complexes immuns
circulants, une protéinurie, et une glomérulonéphrite proliferative avec
des depOts dans le mésangium et dans l'anse capillaire des constituants
immunologiques. Une augmentation du transfert des molecules de
ferritine anionique s'est produite a travers les parois capillaires avec et
sans depOts denses aux electrons demontrables; des détachements de
l'CpithClium visceral n'étaient pas visibles, et Ic transport épithélial de
ferritine anionique était negligeable. La perle des groupes anioniques
était importante dans les anses capillaires glomérulaires avec et sans
depOts denses aux electrons associCs. Ces résultats indiquent qu'une
augmentation de Ia permeabilite glomerulaire pourrait precéder Ic dépôt
des agents immunologiques dans Ia paroi capillaire; que Ia filtration de
macromolecules peut se produire a travers des parois capillaires avec
ou sans depots immuns démontrables; et que Ia perle des groupes
anioniques de Ia membrane basale glomerulaire et l'augmentation de Ia
filtration de macromolecules peuvent se produire en l'absence de
détachements focaux de l'épithélium visceral.
In various forms of glomerular injury, alterations in glomeru-
lar permeability to plasma proteins result in pathologic protein-
uria. The increased filtration of proteins that occurs in immune
complex disease, for example, is due to non-uniform loss of
glomerular barrier function, which happens because of alter-
ations in size-selective and charge-selective properties of the
capillary filter [1, 2]. Specifically, macromolecules such as
native ferritin permeate the glomerular basement membrane
(GBM), predominantly in areas adjacent to deposits of immuno-
reactants, and leak into the urinary space through residual
epithelial slits [1]. Such a mechanism of enhanced filtration of
macromolecules has been verified in Heymann nephritis [3],
murine lupus nephritis [1], and chronic serum sickness nephritis
[4].
The pathogenesis of the proteinuria found in early stages of
immune complex disease, however, is less clear. Recent work
from our laboratory [5] suggested that the permeability of the
glomerular capillary wall (GCW) might be increased before
immune complexes are deposited, and that an alteration in
charge-based barrier function might be a significant pathogenet-
ic mechanism. Nevertheless, other possibilities such as focal
detachment of cells from the GBM [6—9], or increased vesicular
transport of proteins by the visceral epithelium [10], could also
represent alternative, or concurrent, mechanisms that might
account for the increase in permeability.
In the present study, we investigated the pathogenesis of the
enhanced filtration of albumin and native (anionic) ferritin (AF)
that occurs in mice with immune complex glomerulonephritis
induced by the administration of bacterial lipopolysaccharide
(LPS) [11]. This animal model presents features that are often
encountered in various human glomerulonephritides, particu-
larly those associated with infections in which polyclonal
activation of B cells is a central feature. The study demonstrat-
ed that during the induction of glomerulonephritis by immune
complexes, an enhanced filtration of macromolecules may
precede local deposits of immunoreactants in the GCW; that
macromolecules permeate capillary loops with or without asso-
ciated immune deposits; and that the attendant proteinuria is a
reflection of an impairment of glomerular barrier function based
on charge-effect and on size-effect.
Methods
The experimental animals, Balb/c female mice, 8 to 12-
weeks-old were purchased from Charles River, France, Saint
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Aubin-les-Elbeut, France, and from Timco Breeding Labora-
tories, Houston, Texas. The mice were kept under standard
laboratory conditions with free access to water and food.
Lipopolysaccharide (LPS) from Salmonella minnesota Re
595 (lot 102557, Calbiochem-Behring Corporation, La Jolla,
California) was diluted in sterile saline shortly before use. The
concentration was adjusted to deliver 50 g in a 0,2-mi aliquot,
and the preparation was injected intraperitoneally twice a week.
Two tracers were separately used in the studies. The AF
(Polysciences, Inc., Warrington, Pennsylvania), 125 mg/mI,
was extensively dialyzed against the saline before use. The
cationized ferritin (CF) was prepared according to the method
of Danon et al [121. When the cationization reaction proceeds at
a pH of 6.5, CF derivatives suitable for systemic infusion can be
obtained [2, 13]. After extensive dialysis against saline, the final
CF solution was sterilized by filtration and adjusted to a protein
concentration of 25 mg/mI. Details of tracer preparation and
isoelectric point (p1) estimates of ferritins have been published
previously [21. Some of the experiments were performed with
CF, labeled with [1251] Na (Radiochemical Centre, Amersham,
England); the chloramine-T method was used for radiolabelling
[14]. The gel permeation profiles were similar when either the
unlabelled or the '251-labelled CF was applied to a G-200
sephadex column (Pharmacia Fine Chemicals, Uppsala,
Sweden).
Fluorescein-conjugated antimouse IgG, 1gM, and C3 were
purchased from Nordic Immunological Laboratories, Tilburg,
The Netherlands. The tests to verify the specificity of conju-
gates were similar to those we have used previously [15].
Laboratory determinations. Plasma concentrations of C3
were estimated by radial immunodiffusion [16], with antiserum
to mouse C3 purchased from Nordic Immunological Labora-
tories. The values of individual plasma samples were referred to
a standard curve, made with a pool of ten normal plasma
samples, and the results were expressed as a percentage of
normal.
Circulating immune complexes were determined by a solid-
phase conglutinin binding test [17]. Conglutinin was prepared as
described by Maire, Barnet, and Lambert [18], and antibody to
mouse IgG (Fab specific) was labelled with [1251] Na by a
lactoperoxidase procedure [19]. Macromolecular complexes
that carry C3bi bind to the solid-phase conglutinin.
Urinary protein concentration was determined after urine had
been collected over a 24-hr period in an adapted metabolic cage,
and the albumin content was estimated by radial immunodiffu-
sion [16], with serum albumin of known concentration used as
the standard. Monospecific antibody to mouse albumin was
purchased from Nordic Immunologic Laboratories.
Protocol. Twenty Balb/c mice were injected intraperitoneally
with 50 g of LPS, twice a week for 5 weeks. This administra-
tion schedule of LPS results in elevated serum concentration of
gamma-globulins; circulating immune complexes; and immune
complex-mediated glomerulonephritis. Blood and urine sam-
ples were collected before and after completion of LPS injec-
tions. After the 5 weeks of LPS, AF (1.5 mg/g body weight) or
CF (0.4 mglg body weight) was injected into the systemic
circulation, and kidney samples were obtained 5 mm thereafter
for immunopathologic studies. Ten mice that were not injected
with LPS served as controls.
For light microscopic studies, tissue samples were fixed in
Bouin's fluid and embedded in glycol-methacrylate, and sec-
tions were stained with hematoxylin and eosin, and the period-
ic-acid Schiff reagent. For immunofluorescent studies, tissue
samples were processed and analyzed as described previously
[15]. For electron microscopic studies, the specimens were
processed according to a routine protocol [15] with the follow-
ing exceptions: the fixative used was 2.5% glutaraldehyde
(Fluka, A. 0., Zurich, Switzerland) in phosphate buffer, pH
7.2; before dehydration, the specimens were exposed to osmi-
um tetroxide reduced by potassium ferrocyanide, a treatment
that enhances the visualization of ferritin molecules in tissue
section [20]; and sections were examined and photographed
unstained, or stained with lead citrate [21].
We examined three or more glomeruli ultrastructurally in
each experiment performed; over the course of the study, more
than 500 ultrathin sections were examined. Survey photographs
were taken from each glomerulus, and a diligent search was
made for the presence of visceral epithelial detachments and
vesicular transport of AF. Kidney specimens from mice inject-
ed with CF were fixed by immersion, since previous studies [2]
(with either immersion or in situ fixation techniques used) did
not demonstrate appreciable differences in distribution of an-
ionic sites of the GBM.
The Student t test for paired samples was used to analyze the
albumin excretion data; P < 0.05 was considered significant.
Results
All mice tolerated the LPS administration well. Twenty mice
received LPS, and ten served as uninjected controls; half of the
mice in each group received AF and the other half CF.
The p1 of AF was 4.2 to 4.6, and that of CF was 7.7 to 8.5.
The CF preparation was monomolecularly dispersed, and when
1.0 mg of CF was added to a suspension of mouse red blood
cells (l0), no aggregation was visible.
After 5 weeks of LPS, plasma C3 was normal; the mean
amount of C3bi-carrying material that bound to conglutinin was
12.05 ng/ml of '251-IgG equivalent (control mice = 1.65 ng/ml);
and mean 24-hr albumin excretion was 84.4 g/24 hr (range =14
to 166 gI24 hr) [control mice 12.6 ig/24 hr (range = < 3 to 30
g/24 hr)].
On light microscopic study of kidney tissue from LPS-
injected mice, we observed that the glomeruli were enlarged,
the total number of cells was increased, endothelial mitoses
were frequent, and capillary loops were infiltrated with substan-
tial numbers of granulocytes and mononuclear cells. On immu-
nofluorescence microscopic study, granular deposits of IgG,
1gM, and C3 were visible in mesangia and in several, although
not all, capillary loops. Control mice exhibited normal glomeru-
li, but some had trace amounts of 1gM in mesangia.
In the control mice, AF molecules were confined largely to
the lamina rara interna and the luminal third of the lamina densa
of the GBM (Fig. 1). In mice injected with LPS, AF molecules
were seen throughout the width of the GBM, and many were
present in the adjacent urinary space, in capillary loops, both
without (Fig. 2) and with (Fig. 3) associated electron-dense
deposits. AF molecules were not accumulated in the slit-pore
area. Loss of foot processes was focal and variable, and the
number of AF molecules in the urinary space did not correlate
with the extent of deposited electron-dense material (compare
Figs. 2 and 3). Focal detachments of visceral epithelium were
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Fig. 1. Detail of a glomerular capillary wall of a control mouse injected with native ferritin. The tracer molecules are largely restricted to the
luminal third of the basement membrane (B), and no molecules are seen in vesicles of the visceral epithelium (Ep) or in the urinary space (US). En
represents endothelial cell. (Lead citrate stain, x73,500)
Fig. 2. Detail of a glomerular capillary wall of a mouse that received lipopolysaccharide and was injected with native ferritin (AF). Note
permeation of the basement membrane (B) by AF molecules that are also seen in large numbers in the urinary space (US). Focal detachments of the
visceral epithelium (Ep) or vesicles containing AF molecules are not present. Electron-dense deposits are not seen. En represents endothelial cell.
(Lead citrate stain, x73,500)
Fig. 3.Detail of a glomerular capillary wall of a mouse that received lipopolysaccharide and was injected with native ferritin (AF). Electron-dense
deposits (D) are wedged in the slit pores. Note permeation of the basement membrane by AF molecules that are also seen in the urinary space (US).
Focal detachments of the visceral epithelium (Ep) or vesicles containing AF molecules are not present. En represents endothelial cell. (Lead citrate
stain, ><73,500)
not seen, and epithelial vesicles containing AF molecules were
rare, or (more often) absent (Figs. 2 and 3).
In control mice, CF molecules labelled the laminae rarae of
the GBM and, occasionally, the slit-pore area; anionic sites of
the endothelial plasma membrane were not visibly labelled, and
no CF molecules were seen beyond the slit diaphragm (Fig. 4).
In mice injected with LPS, the labelling of the laminae rarae of
the GBM was diminished (Figs. 5 and 6), most notably in the
lamina rara externa, where in most segments, CF molecules
were virtually absent, whether or not electron-dense deposits
were present (compare Figs. 5 and 6). In addition, the distribu-
tion of CF molecules was less uniform; in the lamina rara
interna, they were seen in groups of 10 to 15 each, with
unlabelled segments of GBM between them (compare Figs. 4,5,
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Fig. 4. Detail of a glomerular capillary wall of a control mouse injected with cationizedferritin. The tracer molecules bind to and demarcate anionic
sites of the basement membrane (B). Abbreviations are: En, endothelial cell; Ep, epithelial cell; US, urinary space. (Lead citrate stain, x73,500)
Fig. 5. Detail of a glomerular capillary wall of a mouse that received lipopolysaccharide and was injected with cationizedferritin. Note reduction in
number of anionic sites of the basement membrane (B) and "patching" of residual sites in the lamina rara interna. Electron dense deposits or
epithelial (Ep) detachments are not seen. Other abbreviations are: En, endothelial cell; US, urinary space. (Lead citrate stain, x73,500)
Fig. 6. Detail of a glomerular capillary wall of a mouse that received lipopolysaccharide and was injected with cationizedferritin. Electron dense
deposits (D) are wedged in the slit pores. Note reduction in number of anionic sites in the basement membrane (B). Residual anionic sites are
virtually limited to the lamina rara interna. Epithelial (Ep) detachments are not seen. Other abbreviations are: En, endothelial cell; US, urinary
space. (Lead citrate stain, x73,5tJ0)
and 6). Focal detachments of the visceral epithelium were not containing about 106 cpm. Five minutes later, the plasma
seen. concentration of CF was 7 and 6% of the injected amount in
Although control and LPS-injected mice received the same
relative amount of CF, the clearance of CF might well have
been altered by the action of LPS, which could result in a
decreased concentration of CF in the circulation and a dimin-
ished labelling of anionic sites of the GBM. To verify this
possibility, in separate experiments, four LPS-injectcd and four
control mice were each given '251.CF, 0.4 j.gIg body weight,
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LPS-treated and control mice, respectively.
To ensure that the loss of anionic groups of the GBM did not
result from a direct effect of LPS, two separate experiments
were performed. In the first experiment, we injected five mice
with 50 jig of LPS each and 3 days later they received CF
intravenously, 0.4 rng/g body weight. Five uninjected mice
received CF only and served as controls. Izui et al [11] have
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demonstrated that such mice do not develop immune complex-
es in the first 3 days following LPS administration. In the
second experiment, four mice were used and we delivered LPS
(20 g) directly into the left kidney by perfusion, followed by a
CF solution (3.0 mg/mI) containing LPS (10 gfm1). In two
control mice, the kidneys were perfused with saline and then
with CF (3.0 mg/ml). No differences were noted in the distribu-
tion of anionic sites in glomeruli exposed to LPS, compared to
that of controls.
Discussion
Our findings demonstrate that Balb/c mice injected with
bacterial LPS for 5 weeks developed a proliferative glomerulo-
nephritis, with deposits of immunoreactants in mesangia and
capillary loops, at a time when C3bi-containing complexes were
present in the circulation. The induction of glomerulonephritis
in such mice resulted in an increase in glomerular permeability
to proteins as evidenced, first by a sevenfold increase in the
excretion of albumin (P < 0.05), and second, by an increased
transfer of AF molecules across the GCW (both, in comparison
to findings in control mice). The present studies also demon-
strated that an appreciable transfer of macromolecules can
occur across GCW with slight morphologic changes (for exam-
ple, Fig. 2), and that neither demonstrable deposits of immuno-
reactants, nor focal detachments of the visceral epithelium from
the GBM, is a prerequisite for enhanced glomerular filtration of
macromolecules in this animal model.
It is unlikely that vesicular epithelial transport contributed
significantly to the transfer of AF molecules from the GBM to
the urinary space. First, the interval between infusion of AF
and the excision of the specimen for study was too short (5 mm)
for any substantial vesicular transport to occur 1311. Second,
vesicles containing AF were virtually absent from the epitheli-
urn. That leakage of AF molecules as a result of focal detach-
ments of the epithelium must have been negligible is indicated
by the absence of epithelial detachments from the GBM in more
than 500 sections of 60 glomeruli examined. Thus, although
focal detachments of epithelium must remain an important
morphologic correlate of increase in glomerular permeability in
other forms of glomerular injury [6—9, 22, 23], an alternative
mechanism must be evoked to explain the permeability charac-
teristics of the GCW in the early phase of immune complex
disease. In the context of the foregoing and in view of the
findings on our micrographs, the transfer of macromolecules
from the GBM to the urinary space occurred, in all likelihood,
via slit pores. Indeed, several reports have documented en-
hanced or abnormal transit of macromolecules (for example,
serum albumin, AF) through slit pores (in the absence of
epithelial detachments) when negative sites of the GBM were
depleted [2, 24, 25].
To study anionic sites of the GBM, we used CF, p17.5 to 8.6.
In previous experiments, this CF preparation labelled anionic
sites of biological membranes satisfactorily [2, 131. In fact, in
control mice, anionic sites of the laminae rarae of the GBM and
slit-pore area were well demarcated, whereas binding of CF
molecules to the plasma membrane of red blood cells and
endothelia was negligible. Such findings in control mice are
similar to those reported by other investigators, using CF
preparations of comparable p1 [26, 27].
In contrast, in the GBM of proteinuric mice, anionic sites
were profoundly altered, in both number and distribution,
(whether or not immune deposits could be demonstrated), and
the slit-pore area was poorly labelled by CF molecules—or not
at all. That the decreased labelling of anionic sites in the GBM
of proteinuric mice did not result from a decreased concentra-
tion of CF in the circulation was confirmed in experiments in
which we used 25I-CF. Further, that the loss of anionic groups
was not due to a direct effect of LPS was excluded by
appropriate experiments. From these observations, we surmise
that loss of anionic sites, in this animal model, may precede
demonstrable deposits of inimunoreactants in the GBM. More-
over, the transfer of AF molecules across the GCW and the
enhanced filtration of albumin, together with depleted anionic
sites of the GBM, would be consistent with an impairment of
glomerular barrier function based on size-effect and charge-
effect if, as reviewed by Farquhar [28], such anionic sites might
endow the GBM, in part, with the properties of a selective
filter. In support of such a concept, the work of Barnes et a! [29]
indicates that loss of anionic groups, as induced by polycations,
also alters size-based barrier function.
Our studies were not designed to elucidate whether serum
factors, or leukocytes, contributed to the increase in glornerular
permeability to macromolecules in LPS-injected mice. Never-
theless, complexes containing C3bi were increased in the
circulation when pathologic proteinuria developed; the concen-
tration of complement, reflected by plasma C3, however,
remained normal. Such findings are not unique, or unexpected,
as exemplified by membranous nephropathy in humans and in
Heymann nephritis; in either condition, serum complement is
consistently normal in the presence of heavy proteinuria or the
nephrotic syndrome. Yet, as demonstrated by Salant et al [301,
complement is essential for the induction of proteinuria in
Heymann nephritis.
Glomerular injury and proteinuria, however, can also result
from mechanisms that do not involve complement. Evidence
reviewed by Cotran 1311, for example, indicates that monocytes
may play an important role in the induction of glomerulonephri-
tis. Reduction in the number of monocytes by means of total
body irradiation, or antimacrophage serum, was reported to
result in the inhibition of glomerular infiltration by monocytes,
pronounced reduction of proteinuria in anti-GBM nephritis [32],
and acute serum sickness nephritis [33]. As indicated previous-
ly, monocytes were detected in substantial numbers in the
glomeruli of LPS-injected mice. Whether complement or mono-
cytes, or both, play a role in the pathogenesis of proteinuria in
the glomerulonephritis induced by polyclonal B-cell activators,
such as LPS, remains to be determined.
Finally, although our findings are consistent with the notion
that the permeability of the GCW is increased before immune
complexes can be locally demonstrated, this notion must be
tempered by the realization that immune deposits not detect-
able by the methods we used might have been deposited. If this
is the case, then immune complex-related recruitment of leuko-
cytes and release of hydrolytic enzymes could potentially have
contributed to the observed increase in glomerular permeability
and proteinuria.
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